Demand for Medical Gloves Pushes Record Rubber Gloves Exports
The Malaysian Rubber Glove Manufacturers Association (MARGMA) has forecast that rubber glove exports are expected to increase by 23 percent to 8.8 billion. And according to a report in Business Times, Malaysia was expected to post record rubber glove exports for the eighth straight year in 2010, driven by higher global demand for medical gloves. The report notes, "Last year, the country exported close to 100 billion pieces of rubber gloves to more than 180 countries. This volume makes up two-thirds of the global market for rubber gloves. Healthcare products like medical gloves continue to see strong demand despite the current lackluster global economic growth."
According to the International Rubber Study Group (IRSG), global rubber consumption reached 23.1 million tons in the 12 months leading up to June 2010, 11.2 percent higher than at the same point in 2009. Global rubber demand is forecast to reach 23.9 million tons in 2010 and 25.5 million tons in 2011; natural rubber demand is expected to be around 114,000 tons higher in 2010, at 10.3 million tons, compared to the previous forecast. Global natural rubber production is forecast to rise by 6.1 percent to 10.25 million tons in 2010 and by an additional 7.3 percent to 11.0 million tons in 2011.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
